Literature DB >> 2608589

The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus.

J G Hanly1, S Behmann, S D Denburg, R M Carbotte, J A Denburg.   

Abstract

To determine the significance of changes in serum antineuronal antibody levels in systemic lupus erythematosus, 9 patients who had a rise and 11 patients who had a fall in neuronal antibody titre over a mean duration of 2.1 years (range 0.25-5.2) were identified. These changes were examined in the light of concurrent changes in other serological variables, overall disease activity, neuropsychiatric disease and neuropsychological tests. Changes in antineuronal antibodies were frequently associated with concurrent changes in anti-DNA antibodies and overall disease activity. When neuropsychiatric disease or cognitive dysfunction were present, their course showed a close correlation with changes in antineuronal antibody levels. The results support the association between antineuronal antibodies and neuropsychiatric-systemic lupus erythematosus, but suggest that their measurement will provide useful information of disease status in only a subpopulation of patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2608589      PMCID: PMC2429197          DOI: 10.1136/pgmj.65.767.622

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  22 in total

1.  A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus.

Authors:  J G Hanly; S Rajaraman; S Behmann; J A Denburg
Journal:  Arthritis Rheum       Date:  1988-12

Review 2.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

3.  Antineuronal antibodies in brain tissue of patient with systemic lupus erythematosus.

Authors:  T Inoue; M Okamura; K Amatsu; A Ohe; N Kato; Y Kanayama
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

4.  Central nervous system lupus--diagnosis and treatment.

Authors:  G R Hughes
Journal:  J Rheumatol       Date:  1980 May-Jun       Impact factor: 4.666

5.  Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis.

Authors:  P Lee; M B Urowitz; A A Bookman; B E Koehler; H A Smythe; D A Gordon; M A Ogryzlo
Journal:  Q J Med       Date:  1977-01

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus.

Authors:  H A Wilson; J B Winfield; R G Lahita; D Koffler
Journal:  Arthritis Rheum       Date:  1979-05

8.  An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus.

Authors:  B Bresnihan; M Oliver; B Williams; G R Hughes
Journal:  Arthritis Rheum       Date:  1979-04

9.  Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; G W Williams; A D Steinberg
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

View more
  6 in total

1.  Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens.

Authors:  I J Alosachie; J W Terryberry; D Mevorach; Y Chapman; M Lorber; D Torre; P Youinou; J B Peter; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Antibodies to protein P in systemic lupus erythematosus.

Authors:  L S Teh; A E Bedwell; D A Isenberg; C Gordon; P Emery; P J Charles; M Harper; N Amos; B D Williams
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 3.  Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment.

Authors:  Melanie J Harrison; Lisa D Ravdin
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

Review 4.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 5.  Diagnosis and pathogenesis of CNS lupus.

Authors:  A P van Dam
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

6.  Assessment of cognitive function in patients with systemic lupus erythematosus.

Authors:  D Mulherin; E Doherty; A O'Connell; B Bresnihan
Journal:  Ir J Med Sci       Date:  1993-01       Impact factor: 1.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.